Connect with Sona

  •  

Email: info@sonanano.com

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Author Archives: Admin

Sona Engages Sports Marketing Partner to Secure Concussion Test Development Partner

August 31, 2020 – Halifax, Nova Scotia – Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company”), a developer of rapid, point-of-care diagnostic tests, announced today it has engaged Bonham/Wills & Associates (“Bonham/Wills”), a leading sports consulting firm, to assist … Read More

Sona Nanotech COVID-19 Antigen Results

Sona Nanotech Announces Clinical Evaluation Study Results for its COVID-19 Antigen Test

August 25, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”), a developer of rapid, point-of-care diagnostic tests, is pleased to announce that its rapid detection COVID-19 antigen test achieved a sensitivity of 84.6% and … Read More

Sona Antigen for COVID-19

Sona Nanotech Updates on Timing of Clinical In-Field Validation Studies for its COVID-19 Antigen Test

Halifax, Nova Scotia–(Newsfile Corp. – August 6, 2020) – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”), a developer of rapid, point-of-care diagnostic tests, announces that its previously announced clinical, in-field evaluation studies for its rapid detection, COVID-19 antigen … Read More

Maxim Group

Sona Nanotech Engages Maxim Group for NASDAQ Listing and Investment Banking Services, and Announces Organizational Change

Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (“Sona Nanotech” or the “Company”), a developer of rapid, point-of-care diagnostic tests for COVID-19 and other applications, has engaged Maxim Group, LLC (“Maxim”) for general financial advisory and investment banking services in relation … Read More

Sona Nanotech Announces Validation Results for its COVID-19 Antigen Test

July 2, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”), a developer of rapid, point-of-care diagnostic tests, is pleased to announce that its rapid detection, COVID-19 antigen test’s laboratory validation studies of performance levels … Read More

Sona Nanotech Inc. participates in the Coronavirus Virtual Webinar Series

Sona Nanotech Inc. is proud to be a participant of the Coronavirus Virtual Webinar Series, an online-only event occurring on June 17, 2020. A novel coronavirus emerged in China in late 2019; it has been officially named by the World Health … Read More

Sona Nanotech Comments on Trading Activity at Request of IIROC

Sona Nanotech Comments on Trading Activity at Request of IIROC June 1, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”) has been requested by the Investment Industry Regulatory Organization of Canada (IIROC) to comment … Read More

Sona Nanotech Engages MRIGlobal for COVID-19 Test Validation Studies

Sona Nanotech Engages MRIGlobal for COVID-19 Test Validation Studies May 22, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”) is pleased to announce the engagement of MRIGlobal, a leading applied scientific research organization, to … Read More

Sona Nanotech Provides Covid-19 Antigen Test Progress Update

May 12, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”) is pleased to provide the following update on the development of its rapid-response, Covid-19 antigen test.  The Company received confirmation from an independent laboratory … Read More

Sona Nanotech Provides a Progress Update on its Covid-19 Antigen Test

April 13, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”) is pleased to provide an update on the development, manufacturing arrangements and pre-orders for its Covid-19 antigen test.  The Company this past week has: … Read More